1. Jiang, Yanting, Sun, Yue, Hu, Jiandong, Zhou, Chunshui, Xu, Hui. 2019. A germline mutation in Rab43 gene identified from a cancer family predisposes to a hereditary liver-colon cancer syndrome. In BMC cancer, 19, 613. doi:10.1186/s12885-019-5845-4. https://pubmed.ncbi.nlm.nih.gov/31226964/
2. Kretzer, Nicole M, Theisen, Derek J, Tussiwand, Roxane, Murphy, Theresa L, Murphy, Kenneth M. 2016. RAB43 facilitates cross-presentation of cell-associated antigens by CD8α+ dendritic cells. In The Journal of experimental medicine, 213, 2871-2883. doi:. https://pubmed.ncbi.nlm.nih.gov/27899443/
3. Han, Ming-Zhi, Huang, Bin, Chen, An-Jing, Wang, Jian, Li, Xin-Gang. 2017. High expression of RAB43 predicts poor prognosis and is associated with epithelial-mesenchymal transition in gliomas. In Oncology reports, 37, 903-912. doi:10.3892/or.2017.5349. https://pubmed.ncbi.nlm.nih.gov/28075478/
4. Bae, Won Jung, Woo, Kyoung-Jin, Ahn, Ji Mi, Kim, Seokhwi, Lee, Dakeun. 2022. miR-4742-5p promotes invasiveness of gastric cancer via targeting Rab43: An in vitro study. In Biochemical and biophysical research communications, 613, 180-186. doi:10.1016/j.bbrc.2022.05.044. https://pubmed.ncbi.nlm.nih.gov/35597125/
5. Guo, LiMing, Gao, Rui, Gan, JianChen, Li, ShengPing, Tang, Hua. 2020. Downregulation of TNFRSF19 and RAB43 by a novel miRNA, miR-HCC3, promotes proliferation and epithelial-mesenchymal transition in hepatocellular carcinoma cells. In Biochemical and biophysical research communications, 525, 425-432. doi:10.1016/j.bbrc.2020.02.105. https://pubmed.ncbi.nlm.nih.gov/32102752/
6. Steger, Martin, Diez, Federico, Dhekne, Herschel S, Alessi, Dario R, Mann, Matthias. 2017. Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis. In eLife, 6, . doi:10.7554/eLife.31012. https://pubmed.ncbi.nlm.nih.gov/29125462/
智鼠故事 
